The beleaguered $3 billion cancer-fighting agency in Texas approved lucrative taxpayer-funded projects despite unfavorable marks from scientists, kept sloppy records and allowed imprudent relationships between top agency executives and recipients of multimillion-dollar grants, according to a scathing state audit released Monday.